<?xml version="1.0" encoding="UTF-8"?>
<Label drug="aplisol" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  In highly sensitive individuals, strongly positive reactions including vesiculation, ulceration or necrosis may occur at the test site. Cold packs or topical steroid preparations may be employed for symptomatic relief of the associated pain, pruritus and discomfort.



 Strongly positive test reactions may result in scarring at the test site.



 Immediate erythematous or other reactions may occur at the injection site.



 Local hypersensitivity reactions may occur at the injection site including erythema, pruritus, edema, urticaria and rash.



 Systemic allergic reactions including anaphylaxis/anaphylactoid reactions have been reported to occur in association with the use of Aplisol. The reactions, including anaphylaxis, generally occurred within 24 hours of exposure and manifestations included rash, urticaria, edema/angioedema and pruritus.



   To report SUSPECTED ADVERSE REACTIONS, contact Par Pharmaceutical, Inc. at 1-800-828-9393 or FDA at 1-888-INFO-FDA (1-888-463-6332) or www.fda.gov/medwatch/.  
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
